PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K/AKT signaling in tumor cells and phenotypic polarization of macrophages
出版年份 2022 全文链接
标题
PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K/AKT signaling in tumor cells and phenotypic polarization of macrophages
作者
关键词
-
出版物
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 41, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-10-14
DOI
10.1186/s13046-022-02477-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Antitumor activity and molecular mechanism of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition
- (2022) Huimin Sun et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Epigenetic silencing of miR-144/451a cluster contributes to HCC progression via paracrine HGF/MIF-mediated TAM remodeling
- (2021) Junlong Zhao et al. Molecular Cancer
- Proprotein convertase subtilisin/kexin type 9 (PCSK9): A potential multifaceted player in cancer
- (2021) Anindita Bhattacharya et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- PCSK9 and cancer: Rethinking the link
- (2021) Khadijeh Mahboobnia et al. BIOMEDICINE & PHARMACOTHERAPY
- Influence of cholesterol on cancer progression and therapy
- (2021) Shyamananda Singh Mayengbam et al. Translational Oncology
- Tumor-Derived Retinoic Acid Regulates Intratumoral Monocyte Differentiation to Promote Immune Suppression
- (2020) Samir Devalaraja et al. CELL
- Metabolic reprogramming and cancer progression
- (2020) Brandon Faubert et al. SCIENCE
- Pseurotin A as a novel suppressor of hormone dependent breast cancer progression and recurrence by inhibiting PCSK9 secretion and interaction with LDL receptor
- (2020) Khaldoun S. Abdelwahed et al. PHARMACOLOGICAL RESEARCH
- Circulating follicular helper T cells and subsets are associated with immune response to hepatitis B vaccination
- (2020) Mingjuan Yin et al. Human Vaccines & Immunotherapeutics
- Engineering Macrophages for Cancer Immunotherapy and Drug Delivery
- (2020) Yuqiong Xia et al. ADVANCED MATERIALS
- Cholesterol metabolism in drug‑resistant cancer (Review)
- (2020) Aiwen Yan et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Colorectal Cancer Immunotherapy: Options and Strategies
- (2020) Nor Adzimah Johdi et al. Frontiers in Immunology
- EMT, cancer stem cells and autophagy; The three main axes of metastasis
- (2020) Ghader Babaei et al. BIOMEDICINE & PHARMACOTHERAPY
- Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study
- (2020) Caroline J. Bull et al. BMC Medicine
- Coming Back to Physiology: Extra Hepatic Functions of Proprotein Convertase Subtilisin/Kexin Type 9
- (2020) Klaus-Dieter Schlüter et al. Frontiers in Physiology
- MIF family proteins in genitourinary cancer: tumorigenic roles and therapeutic potential
- (2019) Justin C. Penticuff et al. Nature Reviews Urology
- GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition
- (2019) Zhou Yang et al. CANCER BIOLOGY & THERAPY
- The relation between PI3K/AKT signalling pathway and cancer
- (2019) Saeed Noorolyai et al. GENE
- PCSK9 and inflammation: a review of experimental and clinical evidence
- (2019) Amir Abbas Momtazi-Borojeni et al. European Heart Journal-Cardiovascular Pharmacotherapy
- Targeted therapy for colorectal cancer metastases: A review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer
- (2019) Sorbarikor Piawah et al. CANCER
- PCSK9 and inflammation: role of shear stress, pro-inflammatory cytokines, and LOX-1
- (2019) Zufeng Ding et al. CARDIOVASCULAR RESEARCH
- Colorectal cancer
- (2019) Evelien Dekker et al. LANCET
- Metabolic regulation of gene expression by histone lactylation
- (2019) Di Zhang et al. NATURE
- Prognostic role of serum total cholesterol and high-density lipoprotein cholesterol in cancer survivors: A systematic review and meta-analysis
- (2018) Pingting Zhou et al. CLINICA CHIMICA ACTA
- O -GlcNAcylation in oral squamous cell carcinoma
- (2018) Tassaporn Kongkaew et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Oral squamous carcinoma cells promote macrophage polarization in an MIF-dependent manner
- (2018) Mariana Barbosa de Souza Rizzo et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Oxysterols selectively promote short-term apoptosis in tumor cell lines
- (2018) Debora Levy et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Membrane cholesterol access into a G-protein-coupled receptor
- (2017) Ramon Guixà-González et al. Nature Communications
- The administration of drugs inhibiting cholesterol/oxysterol synthesis is safe and increases the efficacy of immunotherapeutic regimens in tumor-bearing mice
- (2016) Claudia Lanterna et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Role of Cholesterol in Cancer
- (2016) Omer F. Kuzu et al. CANCER RESEARCH
- Cellular Cholesterol Directly Activates Smoothened in Hedgehog Signaling
- (2016) Pengxiang Huang et al. CELL
- CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer
- (2016) Hanxiao Xu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Targeting MIF in Cancer: Therapeutic Strategies, Current Developments, and Future Opportunities
- (2016) Ciaran O'Reilly et al. MEDICINAL RESEARCH REVIEWS
- Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9)
- (2015) Rainer Schulz et al. BASIC RESEARCH IN CARDIOLOGY
- Proprotein Convertase Subtilisin/Kexin Type 9 Deficiency Reduces Melanoma Metastasis in Liver
- (2015) Xiaowei Sun et al. NEOPLASIA
- Targeting lactate metabolism for cancer therapeutics
- (2013) Joanne R. Doherty et al. JOURNAL OF CLINICAL INVESTIGATION
- Control of Tumor-Associated Macrophage Alternative Activation by Macrophage Migration Inhibitory Factor
- (2013) K. Yaddanapudi et al. JOURNAL OF IMMUNOLOGY
- Phase 3 data for PCSK9 inhibitor wows
- (2013) Cormac Sheridan NATURE BIOTECHNOLOGY
- Control of the immune system by oxysterols and cancer development
- (2012) Catia Traversari et al. CURRENT OPINION IN PHARMACOLOGY
- Epithelial-mesenchymal transitions: insights from development
- (2012) J. Lim et al. DEVELOPMENT
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The Lipogenesis Pathway as a Cancer Target
- (2011) Hanley N. Abramson JOURNAL OF MEDICINAL CHEMISTRY
- Proprotein convertase subtilisin/kexin type 9 (PCSK9) affects gene expression pathways beyond cholesterol metabolism in liver cells
- (2010) Hong Lan et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- PCSK9-deficient mice exhibit impaired glucose tolerance and pancreatic islet abnormalities
- (2009) Majambu Mbikay et al. FEBS LETTERS
- Genome-wide expression analysis of cells expressing gain of function mutant D374Y-PCSK9
- (2008) Trine Ranheim et al. JOURNAL OF CELLULAR PHYSIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started